Ads
related to: radioactive iodine for thyroid cancer
Search results
Results from the WOW.Com Content Network
Radioactive iodine (iodine-131) alone can potentially worsen thyrotoxicosis in the first few days after treatment. One side effect of treatment is an initial period of a few days of increased hyperthyroid symptoms. This occurs because when the radioactive iodine destroys the thyroid cells, they can release thyroid hormone into the blood stream.
The radioactive iodine uptake test is a type of scan used in the diagnosis of thyroid problems, particularly hyperthyroidism. It is entirely different from radioactive iodine therapy (RAI therapy), which uses much higher doses to destroy cancerous cells. The RAIU test is also used as a follow-up to RAI therapy to verify that no thyroid cells ...
Thyroid cancer accounts for less than 1% of cancer cases and deaths in the UK. Around 2,700 people were diagnosed with thyroid cancer in the UK in 2011, and around 370 people died from the disease in 2012. [69] However, in South Korea, thyroid cancer was the 5th most prevalent cancer, which accounted for 7.7% of new cancer cases in 2020. [70]
Iodine-131 (131 I) is the most common RNT worldwide and uses the simple compound sodium iodide with a radioactive isotope of iodine. The patient (human or animal) may ingest an oral solid or liquid amount or receive an intravenous injection of a solution of the compound. The iodide ion is selectively taken up by the thyroid gland.
This procedure may also be used, with higher doses of radio-iodine, to treat patients with thyroid cancer. The 131 I is taken up into thyroid tissue and concentrated there. The beta particles emitted by the radioisotope destroys the associated thyroid tissue with little damage to surrounding tissues (more than 2.0 mm from the tissues absorbing ...
As thyroid cancer can take up iodine, radioactive iodine is commonly used to treat thyroid carcinomas, followed by TSH suppression by high-dose thyroxine therapy. [6] Nodules are of particular concern when they are found in those under the age of 20. The presentation of benign nodules at this age is less likely, and thus the potential for ...
Seidlin established the Medical Physics Research Laboratory at Montefiore Hospital and its Endocrine Clinic in 1943. [4] In the same year, at Montefiore Hospital in New York City, [5] building on the success of Dr Saul Hertz's use of radioactive iodine to treat Graves' Disease, Seidlin consulted with Dr. Hertz regarding the use of RAI in the treatment of thyroid carcinoma. [6]
In thyroid cancer or Graves' disease, ablation therapy with radioactive iodine (131 I) can be used to remove trace thyroid tissue that may remain after thyroidectomy (surgical excision of the gland). For 131 I therapy to be effective, the trace thyroid tissue must be avid to iodine, which is achieved by elevating the person's TSH levels. [5]
Ads
related to: radioactive iodine for thyroid cancer